Subclinical giant cell arteritis increases the risk of relapse in polymyalgia rheumatica.
Eugenio de MiguelRositsa Valerieva KaralilovaPierluigi MacchioniCristina PonteEdoardo ConticiniSharon CowleyAlessandro TomelleriSara MontiIrene Monjo HenryZguro Anastasov BatalovGiulia KlinowskiPaolo FalsettiDavid J KaneCampochiaro CorradoAlojzija HocevarPublished in: Annals of the rheumatic diseases (2023)
Patients with PMR and subclinical GCA had a significantly higher number of relapses during a 2-year follow-up than patients with isolated PMR. Lower starting doses and rapid glucocorticoid tapering in the first 3 months emerged as risk factors for relapse.